XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.3
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
ASSETS    
Cash and cash equivalents $ 9,388 $ 11,713
Restricted cash and equivalents 142,506 125,684
Finance receivables measured at fair value 3,624,941 3,313,767
Finance receivables, net 977 4,987
Furniture and equipment, net 882 943
Other assets 31,082 36,774
Total assets 3,809,776 3,493,868
Liabilities    
Accounts payable and accrued expenses 67,037 70,151
Warehouse lines of credit 340,645 410,898
Residual interest financing 149,501 99,176
Securitization trust debt 2,916,439 2,594,384
Subordinated renewable notes 28,589 26,489
Total liabilities 3,502,211 3,201,098
COMMITMENTS AND CONTINGENCIES
Shareholders' Equity    
Common stock, no par value; authorized 75,000,000 shares; 22,143,708 and 21,432,698 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 26,171 25,720
Retained earnings 281,404 267,060
Accumulated other comprehensive loss (10) (10)
Total shareholders' equity 307,565 292,770
Total liabilities and shareholders' equity 3,809,776 3,493,868
Preferred Stock [Member]    
Shareholders' Equity    
Preferred stock, value 0 0
Series A Preferred Stock [Member]    
Shareholders' Equity    
Preferred stock, value 0 0
Series B Preferred Stock [Member]    
Shareholders' Equity    
Preferred stock, value $ 0 $ 0